Published in Blood Rev on July 20, 2011
Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun (2013) 2.56
Senescence and apoptosis block hematopoietic activation of quiescent hematopoietic stem cells with short telomeres. Blood (2014) 1.46
Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans. PLoS One (2014) 1.11
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation. Blood (2012) 1.01
Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci (2014) 0.96
The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol (2015) 0.91
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes. J Clin Invest (2015) 0.90
The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med (2014) 0.86
Changes in the frequencies of human hematopoietic stem and progenitor cells with age and site. Exp Hematol (2013) 0.80
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. Biol Blood Marrow Transplant (2016) 0.79
A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant (2016) 0.76
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer (2009) 6.00
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Cancer in dyskeratosis congenita. Blood (2009) 4.28
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature (2011) 2.03
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer (2009) 1.91
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica (2011) 1.71
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY) (2010) 1.62
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.48
Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology (2009) 1.47
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res (2011) 1.37
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control (2009) 1.32
Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood (2002) 1.27
A role for heterochromatin protein 1γ at human telomeres. Genes Dev (2011) 1.22
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol (2013) 1.20
Genome-wide association study of relative telomere length. PLoS One (2011) 1.16
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12
LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet (2010) 1.11
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2006) 1.09
Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. Int J Cancer (2013) 1.08
Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One (2013) 1.07
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control (2011) 1.07
Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet (2013) 1.05
The long and short of telomeres and cancer association studies. J Natl Cancer Inst (2013) 1.04
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet (2012) 1.04
Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia. Br J Haematol (2012) 1.01
Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet (2010) 1.01
H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep (2013) 1.01
A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer (2011) 1.00
Telomere length and risk of glioma. Cancer Epidemiol (2013) 0.94
Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis (2010) 0.92
Response to androgen therapy in patients with dyskeratosis congenita. Br J Haematol (2014) 0.89
The relationship between DNA methylation and telomere length in dyskeratosis congenita. Aging Cell (2011) 0.88
Parathyroid tumor development involves deregulation of homeobox genes. Endocr Relat Cancer (2008) 0.87
On the interplay of telomeres, nevi and the risk of melanoma. PLoS One (2012) 0.87
The evidence for prostate cancer risk loci at 8q24 grows stronger. J Natl Cancer Inst (2007) 0.85
The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. Hum Mol Genet (2011) 0.83
Promoter methylation of candidate genes associated with familial testicular cancer. Int J Mol Epidemiol Genet (2012) 0.83
Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes. Cytogenet Genome Res (2014) 0.81
Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology? Psychosomatics (2012) 0.81
Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohort. Circ Cardiovasc Genet (2014) 0.81
Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer (2014) 0.81
Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth. J Mol Endocrinol (2009) 0.81
Hereditary and environmental epidemiology of sarcomas. Clin Sarcoma Res (2012) 0.80
Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study. Int J Mol Epidemiol Genet (2012) 0.79
Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes. J Clin Endocrinol Metab (2014) 0.78
Semantic deficits in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.77
Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes. Br J Haematol (2013) 0.76
Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatr Blood Cancer (2009) 0.75
Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type. Cancer Epidemiol Biomarkers Prev (2012) 0.75
Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome. J Clin Invest (2016) 0.75
The shelterin complex and hematopoiesis. J Clin Invest (2016) 0.75
Restoration of conceptual knowledge in a case of semantic dementia. Neurocase (2014) 0.75
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. Am J Hum Genet (2011) 0.75